PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) was the target of a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 5,771 shares, a decline of 83.7% from the September 15th total of 35,490 shares. Based on an average daily trading volume, of 138,958 shares, the short-interest ratio is currently 0.0 days.
PharmaTher Stock Down 0.2%
Shares of PHRRF stock traded down $0.00 during midday trading on Friday, reaching $0.04. 20,000 shares of the company were exchanged, compared to its average volume of 157,653. PharmaTher has a 12 month low of $0.03 and a 12 month high of $0.14. The company’s 50 day moving average price is $0.04 and its two-hundred day moving average price is $0.04.
About PharmaTher
PharmaTher Inc is a specialty pharmaceutical company focused on developing and commercializing therapies for diseases with significant unmet medical needs. The company’s strategy centers on repurposing established medicines and advancing pharmaceutical products through clinical development and regulatory pathways.
PharmaTher has primarily focused on ketamine-based treatments and psychedelic medicines. Its development programs have included potential applications of ketamine in neurological and psychiatric conditions, including status epilepticus, Parkinson’s disease and related movement disorders.
Further Reading
- Five stocks we like better than PharmaTher
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
- Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
